Development of 5-Fluorouracil Derivatives as Anticancer Agents

Author(s): Xiaoyan Pan, Chen Wang, Fang Wang, Pengfei Li, Zhigang Hu, Yuanyuan Shan, Jie Zhang

Journal Name: Current Medicinal Chemistry

Volume 18 , Issue 29 , 2011

Become EABM
Become Reviewer
Call for Editor


5-Fluorouracil (5-FU) is one of the most potent antimetabolites which have been widely used in the treatment of advanced solid tumors. As an anticancer agent, because of its low efficacy and high toxicity, numerous modifications of 5-FU structure have been performed. A great number of novel 5-FU derivatives have been developed with highly efficient and much less toxic. In this paper, the recent development of novel 5-FU derivatives as potent antitumor agents is reviewed and discussed.

Keywords: 5-Fluorouracil (5-FU), anticancer, thymidylate synthase, antimetabolite, toxicity, tumor, derivative, macromolecule, pyrimidine, polymer

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2011
Page: [4538 - 4556]
Pages: 19
DOI: 10.2174/092986711797287584
Price: $65

Article Metrics

PDF: 23